Aspect Imaging Announces FDA Clearance of

Wrist 3 MRI System

Point-of-care quality wrist and hand imaging:
Transforming the way patients experience healthcare
Shoham, Israel, 8/3/2016
Aspect Imaging, the world leader of compact high-performance
complete MRI systems and MR technology, announced today that the
U.S. Food and Drug Administration (FDA) has cleared the Company's
Wrist 3 MRI system for diagnostic imaging of the wrist and hand.
Delivering point-of-care affordable MRI, this latest complete solution
from Aspect is a game changer for the healthcare industry. The Wrist 3
makes what was previously only available via a whole body scanner,
now fast and effortless straight from doctors surgeries and clinics.
Patients sit comfortably, inserting only the hand into the magnet. The
system operates silently, with an integrated operator station allowing
close patient contact throughout the process; ensuring a safer and
non-claustrophobic stress-free patient experience.
With the Wrist 3 MRI system, high quality images of the internal
structure of the wrist and hand become affordable and easily available
from almost any point-of-care. This not only improves medical service
efficiency and increases patient satisfaction, but also ensures
substantial money savings for clinics and patients alike. Aspects noncryogen technology and passive self-shielded solution only require a
single-phase standard electrical socket for installation. A small overall
footprint carries minimal installation and running costs with no need
for a specially constructed RF-shielded room.
There is no doubt about the value of MRI-based insights for healthcare
and clinical research. Now, with the Wrist 3 weve overcome the highcost challenge of more conventional MRI systems in scanning the wrist
and hand, opening up a world of potential applications. To give just one
example, rheumatology drug trials are increasingly using MRI of the
hand area as a secondary endpoint to demonstrate drug efficacy. At
Aspect we believe that a dedicated MRI could provide an imaging tool
to support managing rheumatoid arthritis symptoms and treatment on
a routine basis. says Uri Rapoport, Aspect Imagings Founder and CEO.

Initial Wrist 3 MRI system installations are expected during Q3 2016.

About Aspect Imaging:
Aspect Imaging (www.aspectimaging.com) is the world leader in the
design and development of complete compact MRI and NMR systems.
Our unique technology platform is the backbone for a wide range of
products; spanning preclinical, medical, oil & gas and advanced
industrial markets. In the pre-clinical research market, the M-series
compact one-touch MRI systems enable a wide variety of in
vivo applications and research models. The M-series systems are also
used to provide 3D MR-based histology, complementing and directing
pathology and histology-based analysis. In the medical market, Aspect
Imaging has multiple medical programs underway, including highly
efficient just-in-place compact MRI systems, such as the FDA-cleared
Wrist 3 MRI. The companys novel technology is also used in advanced
industrial applications. These include rheology, where the
FlowScan platform provides real-time, online and quantitative
information for process and quality control. In addition, the AI-60
Process Analyzer enables real-time, continuous flow-through stream
analysis, with the ability to provide analysis of dense and opaque
materials such as crude oil.

For further information, please contact:

Dr. Andrew Lonergan
VP Sales and Marketing, Aspect Imaging
alonergan@aspectimaging.com